NCT02604056

Brief Summary

Two arm, pragmatic, cluster-randomized trial, with nursing homes allocated to the full, active intervention (featuring educational outreach offered to each prescriber and team members in the home) or standard quality improvement supports (including online audit and feedback reports for each prescriber in the home). The 'standard' quality improvement supports represent 'usual care' as these are to be launched province-wide; a concurrent control arm with no exposure to a quality improvement intervention is not feasible.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Sep 2015

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2015

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

November 5, 2015

Completed
8 days until next milestone

First Posted

Study publicly available on registry

November 13, 2015

Completed
1.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2017

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2017

Completed
Last Updated

March 23, 2018

Status Verified

March 1, 2018

Enrollment Period

1.6 years

First QC Date

November 5, 2015

Last Update Submit

March 22, 2018

Conditions

Outcome Measures

Primary Outcomes (1)

  • Antipsychotic dispensing

    Number of days with antipsychotic prescriptions in the last week (count, range 0 - 7)

    6 months post-intervention

Secondary Outcomes (12)

  • Antipsychotic prescribing

    3 and 6 months post-intervention

  • Mean Antipsychotic dose

    3 and 6 months post-intervention

  • Benzodiazepine (or sedative) prescribing

    3 and 6 months post-intervention

  • Anti-depressant prescribing

    3 and 6 months post-intervention

  • Acetaminophen prescribing

    3 and 6 months post-intervention

  • +7 more secondary outcomes

Study Arms (2)

Audit + Feedback

ACTIVE COMPARATOR

'Usual care' / standard quality improvement supports (including online Audit and Feedback reports for each prescriber in the home)

Behavioral: Audit + Feedback

Audit + Feedback + Educational Outreach

EXPERIMENTAL

'Active/full' intervention (featuring Educational Outreach offered to each prescriber and team members in the home)

Behavioral: Audit + FeedbackBehavioral: Audit + Feedback + Educational Outreach

Interventions

Online Audit + Feedback practice reports detailing prescribing performance for this class of medication for each prescriber in the nursing home. (Details: http://www.hqontario.ca/Quality-Improvement/Practice-Reports/Primary-Care)

Audit + FeedbackAudit + Feedback + Educational Outreach

The Educational Outreach program will be delivered by academic detailers, health professionals (often nurses or pharmacists) who have received specific intensive training to support prescribing providers in a particular environment, in this case long-term care homes, to make the best or appropriate clinical decisions as possible. It is defined as: "an innovative method of service-oriented educational outreach for front-line clinicians. It combines the interactive, one-on-one communication approach of industry detailers with the evidence-based, non-commercial information of academia." The Educational Outreach will be delivered in addition to online Audit + Feedback practice reports, which detail prescribing performance for this class of medication for each prescriber in the nursing home.

Audit + Feedback + Educational Outreach

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Nursing homes within pre-determined regions of Ontario that expressed an interest in the full intervention (the regions, or hubs, contain a wide variety of nursing home types within a reasonable travel distance \[i.e., \<100 km\])
  • Nursing homes within the hubs in which the medical and administrative leads agree to and support the project

You may not qualify if:

  • Nursing homes with a previous or ongoing involvement in externally supported quality improvement initiatives focusing on antipsychotic medications
  • Nursing homes without any prescribers caring for at least 10 residents routinely
  • Nursing homes with fewer than 30 residents

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (3)

  • Tadrous M, Fung K, Desveaux L, Gomes T, Taljaard M, Grimshaw JM, Bell CM, Ivers NM. Effect of Academic Detailing on Promoting Appropriate Prescribing of Antipsychotic Medication in Nursing Homes: A Cluster Randomized Clinical Trial. JAMA Netw Open. 2020 May 1;3(5):e205724. doi: 10.1001/jamanetworkopen.2020.5724.

  • Desveaux L, Saragosa M, Rogers J, Bevan L, Loshak H, Moser A, Feldman S, Regier L, Jeffs L, Ivers NM. Improving the appropriateness of antipsychotic prescribing in nursing homes: a mixed-methods process evaluation of an academic detailing intervention. Implement Sci. 2017 May 26;12(1):71. doi: 10.1186/s13012-017-0602-z.

  • Desveaux L, Gomes T, Tadrous M, Jeffs L, Taljaard M, Rogers J, Bell CM, Ivers NM. Appropriate prescribing in nursing homes demonstration project (APDP) study protocol: pragmatic, cluster-randomized trial and mixed methods process evaluation of an Ontario policy-maker initiative to improve appropriate prescribing of antipsychotics. Implement Sci. 2016 Mar 29;11:45. doi: 10.1186/s13012-016-0410-x.

Study Officials

  • Noah Ivers

    Family Doctor and Research Scientist

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 5, 2015

First Posted

November 13, 2015

Study Start

September 1, 2015

Primary Completion

April 1, 2017

Study Completion

April 1, 2017

Last Updated

March 23, 2018

Record last verified: 2018-03

Data Sharing

IPD Sharing
Will not share